Background
==========

Computerized tomography angiography (CTA) and magnetic resonance angiography have become widely used in clinical practice with the development of imaging technology; therefore, the detection rate and incidence rate of asymptomatic intracranial artery stenosis have been steadily increasing \[[@b1-medscimonit-24-5729]\]. In recent years there has been increasing clinical attention to focused on cognition impairment secondary to vascular stenosis. The blood supply to the hippocampus, occipital lobe, and lower surface of the temporal lobe is mainly dependent on the posterior cerebral artery (PCA), and these structures are also closely related to memory and cognition \[[@b2-medscimonit-24-5729]\]. However, the relationship between PCA stenosis (PCAS) and cognition remains unclear, and most studies have focused on mechanisms underlying carotid artery stenosis-related cognition impairment. Some clinicians have investigated the influence of hemodynamics after carotid artery stenosis on cognition, but there is still controversy on this issue \[[@b3-medscimonit-24-5729],[@b4-medscimonit-24-5729]\]. Kurata et al. found that hemodynamics after internal carotid artery stenosis was closely related to white matter hyperintensity (WMH) \[[@b5-medscimonit-24-5729]\]. Patankar et al. speculated that major artery stenosis could promote the development of WMH, but the specific mechanism is unclear \[[@b6-medscimonit-24-5729]\]. A recent study revealed that carotid artery stenosis could increase risk of low brain perfusion \[[@b7-medscimonit-24-5729]\], which facilitates development of brain atrophy and cognition decline \[[@b8-medscimonit-24-5729]\]. However, there is no direct evidence supporting a relationship between intracranial artery stenosis and brain atrophy. A variety of studies have been conducted to investigate the mechanism underlying carotid artery stenosis related cognition impairment, but little is known about the relationship between PCAS and cognition impairment. The present study aimed to investigate the relationship of PCAS with brain perfusion, WMH, brain atrophy, and cognition.

Material and Methods
====================

Subjects
--------

The study was approved by the Ethics Committee of Tongji Hospital, and all subjects or their legal representatives gave their written informed consent. Patients with memory decline as the main complaint and without any history of brain infarction were recruited from Tongji Hospital, between Nov. 2015 and Dec. 2016. Using our inclusion and exclusion criteria, we included 65 patients. PCAS was found in 34 patients (left: n=9; right: n=15; bilateral: n=10), in whom there were 12 males and 22 females, with a mean age of 74.71±8.68 years old. In the remaining 31 patients, there were 11 males and 20 females, with a mean age of 64.52±7.68 years old.

Inclusion criteria
------------------

PCAS group: PCAS was diagnosed based on CTA (≥50% stenosis). Control group: Intracranial artery stenosis was not identified by CTA.

Exclusion criteria
------------------

Patients with intracranial artery stenosis except for the posterior cerebral artery were excluded**.** Brain infarction or hemorrhage was excluded by cranial computerized tomography (CT) or magnetic resonance imaging (MRI). Patients with a history of severe brain trauma or atrial fibrillation were excluded. Patients with heart, liver, kidney, or lung dysfunction were excluded. Patients with malignancies or severe infection were excluded. Patients unable to cooperate with examinations due to visual, hearing, or verbal dysfunction were excluded.

CT scanning
-----------

The whole-brain perfusion imaging was done by CT (Toshiba Aquilion ONE 320). Coverage of the brain was 140 mm with volume scanning. Parameters were as follows: slice thickness, 0.5 mm; field of view (FOV), 220 mm; matrix, 512×512; voltage, 100 kV; current, 150 mA. A 50 mL bolus of iodinated contrast agent (iohexol: 350 mg/ml) was injected at 5 ml/s into the antecubital vein, and the first scanning was done 7 s later. Thereafter, intermittent scanning was done with 2 s interval after 12 s. In the arterial phase, the image was visualized after 12 s and peaked at 18--28 s. In the venous phase, intermittent scanning was done every 5 s, from 40 s to 60 s. The single rotation time was 0.5 s and total scanning time was 60 s. Total volume data were obtained.

MRI scanning
------------

Superconducting magnetic resonance (Siemens, Germany) and standard orthogonal coil were used for MRI. In brief, patients were placed in a supine position with the head fixed on a head pad. A standard head coil was used. Then, plain scanning was performed first under the following parameters: for T1-weighted scanning: TR, 1530 s; TE, 9 ms; slice thickness, 5 mm; internal, 1 mm; FOV, 230×230 mm, and for T2-weighted scanning: TR, 4210 ms, TE, 96 ms; slice thickness, 5 mm; interval, 1 mm, FOV, 230×230 mm; FLAIR scanning, TR, 5000 ms; TE, 94 ms; TI, 1800 ms; slice thickness, 5 mm; interval, 1 mm; FOV, 230×230 mm.

Construction of cerebral blood flow map and production of CTA data
------------------------------------------------------------------

The Perfusion Mismatch Analyzer (PMA; Advanced Medical Science Center, Iwate Medical University, Iwate, Japan) was used to calculate the cerebral blood flow (CBF). The software automatically selects ten arterial input functions (AIFs) in one slice, which was set at the level of the Circle of Willis. The venous output function (VOF) was automatically chosen in the intracranial veins above the skull base. The perfusion map was calculated with convolution method with matrix of 512×512, slice thickness of 0.1 mm and other default values in PMA. For quantification, the perfusion map after PMA reconstruction was input into Mango (*<http://rii.uthscsa.edu/mango/>*), and the region of interest (ROI) was delineated. The volume data were input into a 3-D CTA imaging system (Toshiba) for subtraction angiography. The 3-D images were obtained from CTA.

Assessment of intracranial artery stenosis
------------------------------------------

The Warfarin-Aspirin Symptomatic Intracranial Disease (WASID) method \[[@b9-medscimonit-24-5729]\] was used to assess the intracranial artery stenosis as% stenosis=1--(diameter of stenotic artery/diameter of distal normal artery)×100. The bilateral internal carotid arteries, anterior cerebral artery, vertebral artery, basilar artery, and PCA were assessed for stenosis ([Figure 1](#f1-medscimonit-24-5729){ref-type="fig"}). Image analysis was performed on a consensus basis with all images examined as distinct samples by an experienced neurological physician who was unaware of the radiology reports and clinical history, followed by final verification by a similarly blinded and experienced neuroradiologist. The distribution of stenosis was further analyzed.

Assessment of white-matter lesion
---------------------------------

Three representative layers (centrum ovale, parietal lateral ventricle, and basal ganglia) were selected for the assessment of WMH with the modified Scheltens scoring system \[[@b10-medscimonit-24-5729]\]. The periventricular areas (antecornu, postcornu and para-lateral ventricle) were assessed for hyperintensity: 0, no change; 1, lesion smaller than 5 mm; 2, lesion of 6--10 mm. The deep white matter was assessed at the areas supplied by the anterior cerebral artery and middle cerebral artery, the subcortical area supplied by the middle cerebral artery, and the area supplied by PCA: 0, no abnormality; 1, lesion no larger than 3 mm and no more than 5; 2, lesion no larger than 3 mm and no more than 6 mm; 3, lesion of 4--10 mm and no more than 5 mm; 4, lesion of 4--10 mm and no less than 6; 5, lesion no smaller than 11 and no less than 1 mm; 6, merged lesion. The WMH score at different ROIs was obtained. The ROI of the affected side was used for unilateral artery stenosis; the mean WMH score of bilateral ROIs was obtained for patients with bilateral artery stenosis and those in the control group. One was used as the cut-off value in the assessment of WMH, and the incidence of WMH at different ROIs was compared between 2 groups.

Acquisition and measurement of blood flow perfusion at different ROIs
---------------------------------------------------------------------

The CBF map was input into Mango (*<http://rii.uthscsa.edu/mango/>*), and ROI was determined at the centrum ovale, parietal lateral ventricle, and basal ganglia layers. The CBF of different ROIs was calculated. At these layers, the CBF was calculated at bilateral areas supplied by the anterior cerebral artery, the area supplied by middle cerebral artery, the subcortical area supplied by the middle cerebral artery, the area besides the ventricle, and the area supplied by PCA and the hippocampus. The sinus, large vessels, and ventricles were avoided during the measurement of CBF. The CBF of ROI at different layers was determined. The CBF of ROI of the affected side was used for unilateral artery stenosis; the mean CBF of bilateral ROIs was obtained for patients with bilateral artery stenosis and those in control group. The mean CBF of ROI was compared between 2 groups.

Assessment of brain atrophy
---------------------------

The brain atrophy was assessed at the centrum ovale, parietal lateral ventricle, and basal ganglia layers using the modified Global Cortical Atrophy Scale \[[@b11-medscimonit-24-5729]\]. The cortex supplied by the anterior cerebral artery, the cortex supplied by the middle cerebral artery, and the cortex supplied by the PCA, posterior cingulate, and hippocampus were assessed for atrophy. The Global Cortical Atrophy Scale was assessed with a 4-point scoring system: 0, no sulcal opening and lobe atrophy; 1, the visualization of sulcal opening peripherally; 2, evident sulcal opening and deepening; 3, evident sulcal opening and gyral thinning. Hippocampal atrophy was assessed with the medial temporal lobe atrophy (MTA) scale, which is a 5-point scale, ranging from 0 to 4: 0, merging of hippocampus and temporal lobe; 1, structural deficiency or unclear structure between hippocampus and temporal lobe; 2, widened structural deficiency or unclear structure; 3, absence of connection between head and body besides findings in grade 2; 4, brain atrophy more severe than in grade 2 without evident hippocampus. We used the atrophy score at different ROIs and hippocampus, with 1 as the cut-off value for the assessment of brain atrophy. The incidence of brain atrophy was compared between 2 groups ([Figure 2](#f2-medscimonit-24-5729){ref-type="fig"}).

Assessment of cognition
-----------------------

The Montreal Cognitive Assessment (MoCA), Chinese version, was used for the assessment of cognition. The MoCA scores range from 0 to 30 and are divided into 7 subscores. The score was increased by 1 when the educational level was ≤12 years, and the accumulative total score was no higher than 30. The total MoCA score was ≥24 for subjects with educational level of primary school or higher and ≥20 for those with education level lower than primary school. Subjects filled in the form in a quiet and calm environment. The total MoCA score and score of each domain were obtained.

Statistical analysis
--------------------

Statistical analysis was performed with SPSS version 20.0. Data are expressed as mean ± standard deviation or percentages, and the demographics were described. The CBF was compared with one-way analysis of variance. The chi-square test was employed for the comparison of percentages. Spearman correlation analysis was used for assessment of the relationship of brain perfusion with WMH, brain atrophy, and cognition. A value of two-sided *p*≤0.05 was considered statistically significant.

Results
=======

General characteristics
-----------------------

There were no significant differences in gender, educational level, smoking status, drinking status, family history, hyperlipidemia, and hyperhomocysteinemia between the 2 groups (*p*\>0.05), but there was a highly significant difference in age between the 2 groups, and significant differences were noted for hypertension and diabetes mellitus (*p*\<0.05) ([Table 1](#t1-medscimonit-24-5729){ref-type="table"}).

Incidence of WMH at different sites
-----------------------------------

In the PCAS group, the deep brain areas had a higher incidence of WMH as compared with the control group (*p*\<0.01). In the PCAS group, the incidence of WMH in the periventricular area (antecornu, postcornu, and para-lateral ventricle) was significantly higher than in the control group (*p*\<0.05) ([Figure 3](#f3-medscimonit-24-5729){ref-type="fig"}).

CBF at different sites
----------------------

In the PCAS group, the CBF at the area supplied by the anterior cerebral artery, the area supplied by the PCA, and the subcortical area supplied by the middle cerebral artery was significantly lower than in the control group (*p*\<0.05). A significant difference was also observed in the hippocampal CBF between the 2 groups (*p*\<0.05), but there was no significant difference in the CBF of the area supplied by the middle cerebral artery (*p*\>0.05). In the PCAS group, the CBF of the area besides the ventricle (antecornu, postcornu, and para-lateral ventricle) was significantly lower than in the control group (*p*\<0.05) ([Figure 4](#f4-medscimonit-24-5729){ref-type="fig"}).

Incidence of brain atrophy
--------------------------

In the PCAS group, the incidences of brain atrophy at the area supplied by the middle cerebral artery and the area supplied by the PCA, posterior cingulate, and hippocampus were significantly higher than in the control group (*p*\<0.01), but there were no significant differences in the incidences of brain atrophy in the area supplied by anterior cerebral artery and the anterior cingulate between the 2 groups (*p*\>0.05) ([Figure 5](#f5-medscimonit-24-5729){ref-type="fig"}).

Correlation of CBF with cognition and WMH severity
--------------------------------------------------

The CBF of the area supplied by the PCA was positively related to total MoCA score (r=0.31, *p*\<0.05) and negatively related to the severity of WMH at the area supplied by the PCA (r=−0.25, *p*\<0.05) ([Figure 6](#f6-medscimonit-24-5729){ref-type="fig"}).

Correlation between CBF and brain atrophy
-----------------------------------------

The CBF of the area supplied by the PCA was negatively associated with the atrophy severity of the cortex supplied by the PCA (r=−0.41, *p*\<0.01), posterior cingulate (r=−0.41, *p*\<0.01), and hippocampus (r=−0.42, *p*\<0.01) ([Figure 7](#f7-medscimonit-24-5729){ref-type="fig"}).

Discussion
==========

Correlation of PCAS with low brain perfusion and cognition
----------------------------------------------------------

Studies have shown that carotid artery stenosis is often accompanied by cognition decline and may be a risk factor of cognition decline \[[@b12-medscimonit-24-5729]\]. Age is an independent risk factor for the development of intracranial atherosclerosis. A study conducted in the South Korean population observed that for every 10 years of age, the odds of intracranial disease increased by 1.2 \[[@b13-medscimonit-24-5729]\] and a highly significant difference were noted in the age in our study. In addition, our results also demonstrated the significant differences in hypertension and diabetes mellitus between the 2 groups in accordance with a previous report \[[@b14-medscimonit-24-5729]\]. Due to the limitations of cross-sectional studies, cohort studies need to be done to confirm these findings. This study showed that the incidence of cognition impairment was as high as 79.4% in patients with PCAS, which was significantly higher than in the control group. This indicated that vascular stenosis was closely related to cognition, which was consistent with a previous report \[[@b15-medscimonit-24-5729]\]. Chronic low perfusion is widely accepted as a potential mechanism underlying the change in cognition of patients with internal carotid artery stenosis \[[@b5-medscimonit-24-5729]\]: the long-term low brain perfusion reduces the blood flow in the brain, chronic cerebral ischemia may cause WMH, and white matter ischemia may cause damage to cognition and memory \[[@b16-medscimonit-24-5729],[@b17-medscimonit-24-5729]\]. This study also revealed that the areas besides the ventricle (antecornu, postcornu, and para-lateral ventricle) and the deep brain areas (supplied by the anterior cerebral artery, middle cerebral artery, and PCA) were more likely to develop low perfusion. We speculate that this might be related to the vascular distribution in the brain: The deep and superficial perforating arteries meet in a junctional zone, where watershed ischemia or infarct can occur \[[@b18-medscimonit-24-5729]\], periventricular regions areas of the brain that are fed by distal pial end arterioles that form an arterial border zone, and thus is susceptible to the damage induced by systemic or focal reduction in blood flow \[[@b19-medscimonit-24-5729]\].

Correlation of low brain perfusion with WMH and cognition impairment
--------------------------------------------------------------------

Some studies have shown that WMH is closely related to small vessel diseases of the brain \[[@b20-medscimonit-24-5729]\]. Recent studies indicate major artery stenosis may promote the development of WMH \[[@b5-medscimonit-24-5729]\]. In this study, results indicated that the antecornu, postcornu, para-lateral ventricle, areas supplied by the anterior and middle cerebral arteries, subcortical area supplied by middle cerebral artery, and area supplied by PCA in PCAS patients were more likely to develop WMH. There is no consensus on the pathogenesis of WMH, and chronic low brain perfusion theory \[[@b21-medscimonit-24-5729]\], brain blood barrier impairment theory \[[@b22-medscimonit-24-5729]\], inflammatory injury theory \[[@b23-medscimonit-24-5729]\], and age related white matter lesion theory \[[@b24-medscimonit-24-5729]\] have been proposed for the pathogenesis of WMH. The above findings suggest that the antecornu, postcornu, para-lateral ventricle, areas supplied by the anterior and middle cerebral arteries, subcortical area supplied by middle cerebral artery, and area supplied by PCA had reduced perfusion are closely related to low brain perfusion. In addition, this study indicated the change in CBF of the area supplied by the PCA was closely related to the severity of WMH at the area supplied by the PCA and cognition impairment. This suggests that cognition impairment is associated with low brain perfusion and the subsequent development of WMH. The Papez circuit begins with the hippocampus and projects back to the hippocampus via the fornix, mamillary bodies, and posterior cingulate cortex. It has been confirmed that the Papez circuit is closely related to memory \[[@b25-medscimonit-24-5729]\]. Thus, we speculate that the PCAS-related cognition impairment might be related to injury to the Papez circuit. This was a cross-sectional study, and causal relationships should be further validated in more longitudinal studies.

Correlation of low brain perfusion with brain atrophy and cognition impairment
------------------------------------------------------------------------------

Studies had indicated that carotid artery stenosis may cause extensive cortical and subcortical atrophy \[[@b26-medscimonit-24-5729]\]. Kitanit et al. \[[@b27-medscimonit-24-5729]\] conducted a longitudinal study on ischemic vascular diseases, and found that general brain atrophy was positively related to the reduced brain blood flow. This study showed that the incidence of atrophy at the areas supplied by the middle cerebral artery and PCA, posterior cingulate, and hippocampus in PCAS patients was significantly higher than in the control group. Further correlation analysis showed the CBF at the area supplied by the PCA was closely related to the severity of atrophy at these areas. On the basis of vascular distribution, blood supply area of posterior cerebral artery, posterior cingulated and hippocampus were mainly dependent on the PCA. Thus, the occurrence of brain atrophy was closely related to low brain perfusion: (1) The reduced brain perfusion might cause ischemia/hypoxia in bilateral cortexes, which triggered microcirculation disorder and deteriorates neurodegeneration \[[@b28-medscimonit-24-5729]\]; (2) White matter degeneration may cause cortical atrophy: the damage to the connection between white matter fibers may cause secondary cortical injury \[[@b29-medscimonit-24-5729]\]; (3) Hypertension may promote the development of brain atrophy and long-term hypertension may thicken the intima of arterioles in the brain, which reduces brain blood flow and brain perfusion, resulting in diffuse demyelination \[[@b30-medscimonit-24-5729]\]. In addition, there is evidence showing that the occurrence of cognition impairment might be a consequence of accumulative WMH and brain atrophy \[[@b31-medscimonit-24-5729]\]. This suggests that the cognition impairment results from the action of multiple risk factors, and more longitudinal studies were needed to elucidate this issue.

This study investigated the brain perfusion, WMH, and brain atrophy in PCAS patients on the basis of the correlation between PCAS and cognition impairment. Correlation analysis showed that change in brain perfusion at the area supplied by the PCA was significantly related to the severity of WMH and brain atrophy at different sites and cognition decline. These findings indicate that intracranial artery stenosis plays important roles in the occurrence and development of cognition impairment. Thus, we speculate that PCAS causes reduction in focal brain perfusion, which leads to damage to white matter, and long-term ischemia/hypoxia increases the risk for brain atrophy, resulting in the occurrence of cognition impairment.

To the best of our knowledge, this study is the first to investigate the relationship of PCAS with brain perfusion, WMH, brain atrophy, and cognition. Different from previous studies analysis in this study was done at different layers, and the roles of vascular risk factors, imaging findings, and cognition assessment were independently investigated, which is helpful for the identification of lesions at specific layers and sites as well as the severity of lesions. Findings of this study will benefit future clinical diagnosis and treatment of cognition impairment. However, there were still limitations in this study: (1) This was a cross-sectional study with small sample size, and results were preliminary, and more longitudinal studies with large sample size are needed to confirm these findings; (2) White matter lesions and brain atrophy were assessed with a visual assessment scale, which has several limitations (such as being insensitive to small lesions); (3) In the PCAS group, patients with ≥50% stenosis were included, and there were no patients with mild stenosis (\<30% stenosis) and More studies are needed to investigate the imaging findings and clinical behaviors of patients with different severity of PCAS; (4) Collateral circulation was not evaluated in this study, and we could not determine the influence of collateral circulation opening on the brain perfusion. Thus, future studies with larger sample sizes are needed to further investigate the influence of collateral circulation, which will make these findings more convincing.

Conclusions
===========

Old age, hypertension, and diabetes mellitus may be risk factors of PCAS. PCAS patients are more likely to develop cognition impairment. PCAS patients have focal reduction in brain perfusion, and cognition decline is closely related to the reduced perfusion at the area supplied by the PCA. PCAS patients have a higher incidence of WMH, and the change in brain perfusion at the area supplied by the PCA is closely associated with the severity of WMH at the area supplied by the PCA. The incidence of brain atrophy in PCAS patients increases significantly, and the change in brain perfusion at the area supplied by the PCA is closely associated with the severity of brain atrophy.
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![As shown by the red arrow in the figure, only the right posterior cerebral artery develops severe stenosis, while other intracranial arteries are normal.](medscimonit-24-5729-g001){#f1-medscimonit-24-5729}

![Outlines of region of interest (centrum ovale, parietal lateral ventricle and basal ganglia layers) are described as **A, B, C**, respectively. ACA (territory of anterior cerebral artery) is indicated by blue; MCA (territory of middle cerebral artery) is indicated by green; PCA (territory of posterior cerebral artery) is indicated by yellow; Sub_MCA (territory of Sub cortex of Middle cerebral artery) is indicated by red. In panel **B**, antecornu and postcornu are indicated by white, semi-circular areas, which are presented as 1 cm in diameter; periventricular regions territory was indicated by purple; In panel **D**, hippocampus is indicated by pink. From left to right, consisting of relative cerebral blood flow, FLAIR MR, T1-weighted MR. Images in [Figure 1](#f1-medscimonit-24-5729){ref-type="fig"} were obtained from the Department of Radiology of Tongji Hospital.](medscimonit-24-5729-g002){#f2-medscimonit-24-5729}

![Incidence of white matter hyperintensity in different brain areas between the 2 groups. (**A**) Shows deep white matter hyperintensity in different territories in anterior cerebral artery, middle cerebral artery, and posterior cerebral artery. (**B**) Illustrates white matter hyperintensity in periventricular regions. ACA -- territory of anterior cerebral artery; MCA -- territory of middle cerebral artery; PCA -- territory of posterior cerebral artery; Sub_MCA -- territory of subcortex of Middle cerebral artery; antecornu -- territory of antecornu; postcornu -- territory of postcornu; Periventri -- territory of periventricular regions. \* *p*\<0.05, \*\* *p*\<0.01.](medscimonit-24-5729-g003){#f3-medscimonit-24-5729}

![Cerebral blood flow comparison at different sites between the 2 groups. (**A**) Shows CBF of deep regions territories. (**B**) Shows CBF of periventricular regions. (**C**) Shows CBF of Hippocampus. ACA -- territory of Anterior cerebral artery; MCA -- territory of middle cerebral artery; PCA -- territory of posterior cerebral artery; Sub_MCA -- territory of Subcortex of middle cerebral artery; antecornu -- territory of antecornu; postcornu -- territory of postcornu; periventri -- territory of periventricular regions, CBF -- cerebral blood flow. \* *p*\<0.05, \*\* *p*\<0.01.](medscimonit-24-5729-g004){#f4-medscimonit-24-5729}

![Incidence of brain atrophy in different brain structures. (**A**) Demonstrates incidence of brain atrophy in different brain structures. (**B**) Demonstrates incidence of brain atrophy of hippocampus. ACA -- territory of anterior cerebral artery; MCA -- territory of middle cerebral artery; PCA -- territory of posterior cerebral artery; ACC -- territory of anterior cingulate cortex; PCC -- territory of posterior cingulate cortex; \* *p*\<0.05, \*\* *p*\<0.01.](medscimonit-24-5729-g005){#f5-medscimonit-24-5729}

![Correlation between CBF and MoCA score, White matter hyperintensities. (**A**) Illustrated correlation between CBF of PCA territory with total MoCA score. (**B**) Illustrates correlation between CBF of PCA territory with WMH in PCA territory. CBF -- cerebral blood flow; MoCA -- Montreal Cognitive Assessment; PCA -- territory of posterior cerebral artery.](medscimonit-24-5729-g006){#f6-medscimonit-24-5729}

![Correlation between CBF in PCA territory with brain atrophy in posterior cerebral regions. (**A**) Shows correlation between CBF of PCA territory with atrophy score of PCA; (**B**) Shows correlation between CBF of PCA territory with atrophy score of PCC; (**C**) shows correlation between CBF of PCA territory with atrophy score of hippocampus. PCA -- territory of posterior cerebral artery cortex; PCC -- territory of posterior cingulate cortex; HIP -- hippocampus; CBF -- cerebral blood flow.](medscimonit-24-5729-g007){#f7-medscimonit-24-5729}

###### 

Baseline characteristics of the study population.

                                          Control group (n=31)   Stenosis group (n=34)   P value
  --------------------------------------- ---------------------- ----------------------- --------------------------------------------------------------
  Age (mean ±SD)                          64.52±7.68             74.63±8.57              \<0.01[\*\*](#tfn2-medscimonit-24-5729){ref-type="table-fn"}
  Sex (Male %)                            11 (35.5)              12 (35.3)               0.92
  Education years                         10.26±3.17             8.91±4.44               0.17
  Smoking (%)                             5 (16.1)               6 (17.6)                0.87
  Alcohol consumption (%)                 1 (3.2)                2 (5.9)                 1.00
  Hypertension (%)                        12 (38.7)              22 (64.7)               0.036[\*](#tfn1-medscimonit-24-5729){ref-type="table-fn"}
  Diabetes (%)                            3 (9.7)                10 (29.4)               0.047[\*](#tfn1-medscimonit-24-5729){ref-type="table-fn"}
  Family history of dementia (%)          1 (3.2)                2 (5.9)                 1.00
  Hyperlipidemia (%)                      13 (46.4)              17 (70.8)               0.076
  Homocysteine (%)                        0 (0)                  3 (17.6)                0.27
  Whole brain cerebral blood flow (CBF)   32.47±7.82             27.79±8.44              0.024[\*](#tfn1-medscimonit-24-5729){ref-type="table-fn"}
  White matter hyperintensity score       5.5 (2.5, 9.5)         19.5 (11.75, 26.25)     \<0.01[\*\*](#tfn2-medscimonit-24-5729){ref-type="table-fn"}
  Cerebral atrophy score                  2.08 (1, 6.25)         7.5 (3.29, 11.54)       0.001[\*\*](#tfn2-medscimonit-24-5729){ref-type="table-fn"}
  Incidence of cognitive impairment (%)   54.80                  79.40                   0.034[\*](#tfn1-medscimonit-24-5729){ref-type="table-fn"}

*p*\<0.05;

*p*\<0.01.
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